Join our mailing list
  • Contact Us
  • Careers
  • Menu
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
    • Advisory Board (DMD)
    • Contact Us
  • Product Pipeline
    • Pipeline
    • CAP-1002
    • Exosomes
    • Clinical Trials
  • Research
    • Research Overview
    • Duchenne Muscular Dystrophy
    • COVID-19
    • Publications
    • Platforms
      • Cell Therapy
      • Exosomes
  • Investors
    • Corporate Overview
    • Investor Presentation
    • Press Releases
    • Events & Presentations
    • Stock Quote
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
    • Investor Disclaimer
    • Email Alerts
    • Publications
  • Media
    • Press Releases
    • Capricor in the News
    • Events & Presentations

Capricor is Developing First-In-Class Cell and Exosome-based Therapeutics

for the Treatment and Prevention of Diseases

  • News

  • Clinical Programs


    COVID-19
    Learn about HOPE-2 clinical trial
    Duchenne Muscular Dystrophy
  • Social

    Tweets by Capricor

  • About Us
  • Contact Us
  • Press Releases
  • Careers
  • Site Map

© Copyright 2021 Capricor Therapeutics.